Manufacturer VIVEbiotech of Spain is moving into a new plant which will increase its production capacity for lentiviral vectors by 400%.
VIVEbiotech, a gene transfer technologies contract development and manufacturing organization located in Spain, announced on Feb. 24, 2021 that it will be expanding its manufacturing capabilities with new facilities.